Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020.
East Gojam Zone
cervical cancer
precancerous lesions of cervix
visual inspection after acetic acid
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
09
2021
accepted:
10
12
2021
entrez:
10
1
2022
pubmed:
11
1
2022
medline:
11
1
2022
Statut:
epublish
Résumé
Cervical cancer is the commonest cancer of women's reproductive system, and is caused by a progression of precancerous lesions of the cervix. Studies on the prevalence and associated factors of precancerous lesions of the cervix are very limited in Ethiopia, particularly in the study area. This study aimed to assess precancerous lesions of the cervix and associated factors among women of East Gojjam, northwest Ethiopia in 2020. A facility-based cross-sectional study was conducted on 340 cervical cancer-screened women in three hospitals of East Gojjam from February to April 2020. Data were collected by six BSc-qualified nurses who were working in the selected hospitals. EpiData Manager and SPSS 26 were used for data management and analysis. After the data had been clean, descriptive analysis was done and multivariate logistic regression used to identify predictors of precancerous lesions of the cervix. Statistical significance was taken to be Of the 340 recruited women, 15.3% (95% CI 11.83%-19.54%) had precancerous cervical lesions. Mean age was 37.11±9.3 years. Age 46-55 (AOR 3.8, 95% CI 1.21-12.47) years, age 56-65 (AOR 12.26, 95% CI 3.18-47.18) years, residing rurally (AOR 2.04, 95% CI 1.12-3.7), prolonged use of oral contraceptive pills (AOR 9.11, 95% CI 1.14-72.8), history of sexual transmitted infection (STI; AOR 3.40, 95% CI 1.32-8.78), HIV-positive status (AOR 4.89, 95% CI 1.54-15.49), and number of lifetime sexual partners (AOR 9.87, 95% CI 1.38-70.4) were important factors associated with precancerous lesions of the cervix. We found relatively high prevalence of precancerous cervical lesions. Age, rural residence, prolonged use of oral contraceptives, STI, multiple sexual partners, and being HIV-positive were important factors associated with precancerous cervical lesions. Women aged >46 years, with a history of STI, being HIV infected, and with a history of multiple sexual partners should be encouraged to get screened for cervical cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Cervical cancer is the commonest cancer of women's reproductive system, and is caused by a progression of precancerous lesions of the cervix. Studies on the prevalence and associated factors of precancerous lesions of the cervix are very limited in Ethiopia, particularly in the study area.
OBJECTIVE
OBJECTIVE
This study aimed to assess precancerous lesions of the cervix and associated factors among women of East Gojjam, northwest Ethiopia in 2020.
METHODS
METHODS
A facility-based cross-sectional study was conducted on 340 cervical cancer-screened women in three hospitals of East Gojjam from February to April 2020. Data were collected by six BSc-qualified nurses who were working in the selected hospitals. EpiData Manager and SPSS 26 were used for data management and analysis. After the data had been clean, descriptive analysis was done and multivariate logistic regression used to identify predictors of precancerous lesions of the cervix. Statistical significance was taken to be
RESULTS
RESULTS
Of the 340 recruited women, 15.3% (95% CI 11.83%-19.54%) had precancerous cervical lesions. Mean age was 37.11±9.3 years. Age 46-55 (AOR 3.8, 95% CI 1.21-12.47) years, age 56-65 (AOR 12.26, 95% CI 3.18-47.18) years, residing rurally (AOR 2.04, 95% CI 1.12-3.7), prolonged use of oral contraceptive pills (AOR 9.11, 95% CI 1.14-72.8), history of sexual transmitted infection (STI; AOR 3.40, 95% CI 1.32-8.78), HIV-positive status (AOR 4.89, 95% CI 1.54-15.49), and number of lifetime sexual partners (AOR 9.87, 95% CI 1.38-70.4) were important factors associated with precancerous lesions of the cervix.
CONCLUSION
CONCLUSIONS
We found relatively high prevalence of precancerous cervical lesions. Age, rural residence, prolonged use of oral contraceptives, STI, multiple sexual partners, and being HIV-positive were important factors associated with precancerous cervical lesions. Women aged >46 years, with a history of STI, being HIV infected, and with a history of multiple sexual partners should be encouraged to get screened for cervical cancer.
Identifiants
pubmed: 35002317
doi: 10.2147/CMAR.S338177
pii: 338177
pmc: PMC8721437
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9401-9410Informations de copyright
© 2021 Getinet et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests regarding the publication of the paper.
Références
BMC Public Health. 2012 Dec 07;12:1055
pubmed: 23216752
Int J Gynaecol Obstet. 1999 May;65(2):171-81
pubmed: 10405062
J Clin Pathol. 2005 Jun;58(6):671
pubmed: 15917428
BMC Clin Pathol. 2015 Sep 23;15:16
pubmed: 26401120
J Natl Cancer Inst. 1998 Jan 7;90(1):50-7
pubmed: 9428783
Int J Cancer. 2014 Feb 1;134(3):740-5
pubmed: 23900762
Int J Health Sci (Qassim). 2019 May-Jun;13(3):4-9
pubmed: 31123433
Afr Health Sci. 2019 Mar;19(1):1695-1704
pubmed: 31149000
Ethiop Med J. 2015 Jul;Suppl 2:17-24
pubmed: 26591279
J Glob Oncol. 2016 Jun 1;3(1):72-78
pubmed: 28717744
Int J Gynaecol Obstet. 2012 Aug;118(2):103-6
pubmed: 22608027
PLoS One. 2013 Dec 20;8(12):e84519
pubmed: 24376818
Int J Health Sci (Qassim). 2016 Jan;10(1):137-43
pubmed: 27004064
J Oncol. 2016;2016:5473681
pubmed: 27478441
Ethiop J Health Sci. 2015 Oct;25(4):345-52
pubmed: 26949299
J Chronic Dis. 1986;39(12):1051-65
pubmed: 3539967
Clin Obstet Gynecol. 2000 Sep;43(3):433-9
pubmed: 10949747
PLoS One. 2018 Jan 19;13(1):e0191506
pubmed: 29352278
BMC Public Health. 2014 Nov 19;14:1185
pubmed: 25410572
BMC Womens Health. 2008 May 30;8:9
pubmed: 18513406
J Womens Health (Larchmt). 2011 Jun;20(6):943-52
pubmed: 21671779
Med Hypotheses. 1990 Aug;32(4):249-54
pubmed: 2172752
Contraception. 2011 Nov;84(5):512-9
pubmed: 22018127
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
BMC Cancer. 2006 May 23;6:135
pubmed: 16719902
Vaccine. 2012 Nov 20;30 Suppl 4:D1-83, vi
pubmed: 23510764
J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
pubmed: 7791229